Patient Epigenetic Machinery Hijacked by Some Breast Cancer Cells to Evade Drug Therapy

An international team headed by the University of Pittsburgh Cancer Institute (UPCI) says that a breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms. The finding warrants research into adding drugs that could prevent the cancer from hijacking patients' repressive gene regulatory machinery, which might allow the original therapy to work long enough ...

via Medindia Health News More READ